Calls Now Open
2026 Harrington Scholar-Innovator and 2026 Harrington Prize
April 16, 2025
Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants multiple opportunities for funding in addition to expertise from pharma-experienced leaders with a track record of bringing...
Continue ReadingNovember 22, 2022
Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading
November 17, 2022
Study led by University Hospitals and Case Western Reserve University team details a small-molecule drug that lowers cholesterol by 70% in animal models Continue Reading
October 19, 2022
PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading
October 19, 2022
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading
August 18, 2022
Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading
August 15, 2022
Licensing IP for SIK Inhibitors to Radius Health Continue Reading
August 09, 2022
Development of an exercise wearable to help personalize exercise and minimize the risks of dementia. Continue Reading
August 08, 2022
Hope to Help Patients with Retinitis Pigmentosa Continue Reading
August 02, 2022
New therapy seeks to protect from rare muscle-wasting disorder Continue Reading
July 25, 2022
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading